![Miles Nunn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Miles Nunn formerly worked at Amplion Ltd., as Director, Evolutec Group Plc, as Scientific Research Manager, Akari Therapeutics Plc, as Chief Scientific Officer, and Volution Immuno Pharmaceuticals SA, as Chief Scientific Officer.
Dr. Nunn received his doctorate degree from the University of Oxford and undergraduate degree from University College London.
| Sociétés | Poste | Fin |
|---|---|---|
Amplion Ltd. | Directeur/Membre du Conseil | - |
Volution Immuno Pharmaceuticals SA
 Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops anti complement and anti inflammatory molecules as treatments for orphan conditions in the autoimmune and inflammatory diseases sectors | Directeur Technique/Scientifique/R&D | - |
Evolutec Group Plc
 Evolutec Group Plc BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Corporate Officer/Principal | - |
| AKARI THERAPEUTICS, PLC | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Evolutec Group Plc
Evolutec Group Plc BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Volution Immuno Pharmaceuticals SA
Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops anti complement and anti inflammatory molecules as treatments for orphan conditions in the autoimmune and inflammatory diseases sectors | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Amplion Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
